Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2762 (LINC02762)
- Target
- LINC02762
- Molecular classification
- Non-coding RNA, Long intergenic non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 2762 (LINC02762) is a member of the lincRNA subclass, a type of long non-coding RNA (lncRNA) defined as being longer than 200 nucleotides and transcribed from intergenic regions that do not overlap protein-coding genes[5]. LINC02762 is annotated in the human genome and has been incorporated into computational models for cancer prognosis, particularly bladder cancer, as part of multi-lncRNA risk scores. However, its specific biological functions, mechanisms, and therapeutic relevance are not yet characterized. Its general functions, based on lincRNA class activity, may include regulation of gene expression, chromatin remodeling, and transcriptional control, but no detailed mechanistic studies exist for LINC02762 itself[5][4][6].
- Other names
- lnc-PTS-1LINC02762
02
Biological functions
RNA-based regulation of gene expression (general function for lincRNAs)Potential involvement in cancer prognosis as a marker
03
Disease associations
Cancer (suggested as part of a prognosis signature in bladder cancer; role is correlational, not mechanistic)
04
Biomarkers
LINC02762 has been incorporated in molecular signatures as a biomarker for risk stratification or prognosis in bioinformatic models for bladder cancer and potentially other tumors
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2762 (LINC02762).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2762 (LINC02762).